Identification of cancer protein biomarkers using proteomic techniques
Patent
·
OSTI ID:1172149
The claimed invention describes methods to diagnose or aid in the diagnosis of cancer. The claimed methods are based on the identification of biomarkers which are particularly well suited to discriminate between cancer subjects and healthy subjects. These biomarkers were identified using a unique and novel screening method described herein. The biomarkers identified herein can also be used in the prognosis and monitoring of cancer. The invention comprises the use of leptin, prolactin, OPN and IGF-II for diagnosing, prognosis and monitoring of ovarian cancer.
- Research Organization:
- Yale Univ., New Haven, CT (United States)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- FG02-ER63462
- Assignee:
- Yale University (New Haven, CT)
- Patent Number(s):
- 8,975,379
- Application Number:
- 12/644,677
- OSTI ID:
- 1172149
- Resource Relation:
- Patent File Date: 2009 Dec 22
- Country of Publication:
- United States
- Language:
- English
Similar Records
Identification of cancer protein biomarkers using proteomic techniques
Identification of cancer protein biomarkers using proteomic techniques
Identification of cancer protein biomarkers using proteomic techniques
Patent
·
Tue Oct 18 00:00:00 EDT 2016
·
OSTI ID:1172149
Identification of cancer protein biomarkers using proteomic techniques
Patent
·
Tue Jan 01 00:00:00 EST 2019
·
OSTI ID:1172149
Identification of cancer protein biomarkers using proteomic techniques
Patent
·
Tue Feb 23 00:00:00 EST 2010
·
OSTI ID:1172149